Presentation is loading. Please wait.

Presentation is loading. Please wait.

Max Brinsmead MB BS PhD November 2014.  Some 1- 2% of babies will have a major disability that dates from the prenatal period  Either  Chromosomal.

Similar presentations


Presentation on theme: "Max Brinsmead MB BS PhD November 2014.  Some 1- 2% of babies will have a major disability that dates from the prenatal period  Either  Chromosomal."— Presentation transcript:

1 Max Brinsmead MB BS PhD November 2014

2  Some 1- 2% of babies will have a major disability that dates from the prenatal period  Either  Chromosomal disorder e.g. Down syndrome  Structural abnormality e.g. “Hole in the Heart”  Other e.g. Cerebral palsy  While a good deal of antenatal care in the 21 st century is directed to the prenatal detection of these problems....  It is worth remembering that, for most, termination of the pregnancy is the only option

3  All chromosomal abnormalities  About half of the major structural abnormalities  May be difficult in the 1 st half of pregnancy  And varies with the resources available  Very few of the patients with cerebral palsy

4  Diagnostic tests  Have a high degree of accuracy  e.g. Amniocentesis for chromosomes  May be invasive, carry risk and expensive  Screening tests  Cheap and safe tests suitable for whole population  Selects a subgroup for diagnostic testing  So sensitivity and positive predictive value is important  Ultrasound can be used for both screening and diagnosis  Limited only by the resources available

5  Sensitivity  The number of patients selected by the test as positive as a proportion of the total number of patients with the condition sought  e.g. A DRA test that identifies 3 out of 4 mothers with a Down syndrome baby has a sensitivity of 75% and will therefore miss 25% of the babies with this problem  Positive Predictive Value (PPV)  The likelihood that a patient identified by the test has the condition sought  e.g. A DRA with PPV of 10% means that 90% of women selected to undergo amniocentesis will NOT have this condition

6 between Sensitivity and Positive Predictive Value

7 Risk of Baby with Chromosomal Abnormality by Maternal Age Mother's Age at Expected Date of Delivery (Years) Chance of Baby with Down’s Syndrome *At 10-20 wks Chance of live-born baby with a chromosomal abnormality 20 - 241:14201:500 25 - 301:12501:480 31 - 341:11401:420 351:355*1:179 361:300*1:149 371:220*1:124 381:165*1:105 391:125*1:81 401:90*1:64 411:70*1:49 421:50*1:39 431:40*1:31 441:35*1:24 451:25*1:21 461:20*1:16 471:18*1:13 481:14*1:10 491:11*1:8

8  Ultrasound  Nuchal translucency (NT) ↑ with DS  Nasal bone (absent with DS)  Maternal Serum  PAPP-A ↓ with DS  Beta HCG ↑ with DS  AFP ↓ with DS and ↑ with NTDs  Oestriol ↓ with DS  Inhibin-A (useful in 2 nd trimester testing)

9  Use the combined test (i.e NT measure, beta- HCG & PAPP-A )for patients who present in the first trimester  Sensitivity when optimally timed is 85-88%  Can help many patients avoid amnio & CVS  Use the Triple Test (i.e. beta-HCG, E3 and AFP) for patients who present in the 2 nd trimester  Sensitivity when optimally timed is 65 – 75%  Also screens for NTDs  Integrated (1 st & 2 nd trimester) testing offers greater sensitivity and higher PPV but results are late

10 Test/Procedure First Trimester Screening (FTS) Integrated Prenatal Screening (IPS) Serum Integrated Prenatal Screening (SIPS) 1st blood sample11 - 14 weeks *Nuchal translucency ultrasound11 - 14 weeks NONE 2nd blood sampleNONE15 - 20 weeks Results available at:12 - 15 weeks16 - 21 weeks Detection rate (Accuracy)Of every 100 pregnancies with Down syndrome, about 80-85 will be detected (80-85%) Of every 100 pregnancies with Down syndrome, about 85-90 will be detected (85-90%) Of every 100 pregnancies with Down syndrome, about 80-90 will be detected (80-90%) False positive rateAbout 3 to 9 out of 100 pregnancies (3- 9%) About 2 to 4 out of 100 pregnancies (2-4%) About 2 to 7 out of 100 pregnancies (2-7%) Diagnostic test if prenatal screening test is positive CVS 11 - 13 weeks If CVS is not available, you could have amniocentesis diagnostic testing as described in the next column > Amniocentesis 15 - 22 weeks Diagnostic test results available at:13 - 15 weeks17 - 24 weeks Abortion – if you decide to have this – could be performed at: 13 - 23 weeks Abortion timing will depend on local availability 17 - 23 weeks Abortion timing will depend on local availability Or: Continuation with pregnancyBirth

11  Gestational age with accuracy  And this is why ultrasound c NT is so useful  Maternal age  Advancing age will increase the chance of a +ve result  Maternal ethnicity and weight  Multiple pregnancy?  Assisted conception?  Maternal diabetes?  Maternal smoking?

12  From 10w gestation up to 10% of DNA fragments in maternal blood is of fetal origin  Useful for fetal sexing (Y chromosome) and Rh karyotype (RHD gene)  Massively parallel sequencing (MPS) used to quantify total maternal and fetal DNA linked to specific chromosomes  Will detect 99% Down syndrome (excess Ch21)  But only 80 – 92% of Trisomy 13 & 18  Up to 2% plasma unsuitable for testing ◦ Too little DNA esp. in mothers who are ><160 Kg  Tests currently cost $800 - 1400

13  Uses cell-free fetal DNA in maternal blood  Should be regarded as a screening test despite high sensitivity and specificity  Useful for the high risk patient who is very keen to avoid the risks of CVS and amnio  Uncertain role for low risk/unselected group ◦ Does not provide all the information that comes from 1 st trimester ultrasound and maternal triple testing ◦ Cost effectiveness uncertain ◦ Ethical issues e.g. routine fetal sexing?

14  Firstly it is desirable to make a diagnosis before 14w so that TOP is simple and safe  1 st blood test between 9 – 13w&6d  Optimally 10 -12 w  NT measure at 11 – 13w&6d  Optimally at 11.5 – 13.5w  Second trimester blood test 14 – 20w  Optimally 14 – 18w  CVS can be performed any time after 9.5w  Amniocentesis after 15w

15  Full chromosomal analysis from CVS or amnio takes 10 – 14d  Culture failure occurs in <0.5%  Colony mosaicism can be a problem  Some abnormalities can pose dilemmas  e.g. 47 XYY, 47XXY, 45XO  Fast FISH or DNA tests can be done overnight  But are much more expensive  And have a small risk of error

16  Most Down Syndrome babies are born to women over the age of 35  Because my other pregnancies and babies were normal I do not need testing  There is no Family History of Downs so I do not need testing  Husband’s age is important  The chance of aneuploidy after a positive screen test is equivalent to the risk calculated

17  Practitioners of both state that the increased loss associated with both is about 1:100  Large studies say 0.5% for amnio and 1-2% for CVS  Most pregnancy losses occur within 7 – 10d  A few patients leak liquor after amnio  CVS is done PA for an anterior placenta and PV for a posterior placenta  Both procedures require US guidance  And are best done by practitioners of >50/yr

18  What the test is for  And what it will not detect  What is their risk of the condition  What is the likelihood that the test will be positive  What are the sensitivity and PPV of the test  What will they do if the test is positive  What are the risks associated with further testing. What will that test reveal  What will they do if their baby is affected

19  Pre test counselling will help to reduce post positive test anxiety  Resources are required for the optimal management of screen-positive patients  And the continuing care of patients who are screen-positive but amnio/CVS normal  Because they do have pregnancies at increased risk  Consultation with a MFM specialist may be desirable

20  When aneuploidy has been excluded...  Risk of miscarriage <20w is 1.3% for NT 95 – 99 th centile  But is 20% when NT >6.5 mm  Look for cardiac abnormalities  1.7% if NT is 2.5 – 3.4 mm  7.5% if NT >3.5 mm  Is it Cystic Hygroma? i.e. generalised oedema  5-fold increased risk of aneuploidy  12-fold increased risk of cardiac problem  6-fold increased risk of perinatal death  So monitor – consult MFM if it does not resolve

21  When beta-HCG is high exclude Downs  (Trisomy 13 & 18 associated with low beta HCG)  When aneuploidy is excluded....  Monitor for early onset pre eclampsia & IUGR  ? Consult with MFM especially if beta HCG is high  Unexplained elevation of PAPP-A  “Not associated with any known pregnancy problem”

22  Causes include:  Wrong dates  Pregnancy bleeding  Multiple pregnancy  Open neural tube defects*  Anterior abdominal wall defects  Some rare tumours  So refer for tertiary level scanning  and  “Watch carefully” for the rest of the pregnancy

23  Think about: ◦ Placental sulfatase deficiency  X-linked recessive  Ichthyosis (lizard-like skin)  Mild corneal opacification  Cryptorchidism  Smith Lemli-Opitz Syndrome (rare 1:50,000)  Multiple malformtions  Mental retardation  Syndactly ◦ So consider amniocentesis or CVS


Download ppt "Max Brinsmead MB BS PhD November 2014.  Some 1- 2% of babies will have a major disability that dates from the prenatal period  Either  Chromosomal."

Similar presentations


Ads by Google